TipRanks
Hyloris Pharmaceuticals SA (GB:0AB6)
LSE:0AB6
UK Market
0AB6
Hyloris Pharmaceuticals SA
RESEARCH TOOLSreports

Hyloris Pharmaceuticals SA (0AB6) Ratios

1 Followers

Hyloris Pharmaceuticals SA Ratios

GB:0AB6's free cash flow for Q4 2025 was €0.95. For the 2025 fiscal year, GB:0AB6's free cash flow was decreased by € and operating cash flow was €-1.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.89 3.89 4.15 5.22 8.63
Quick Ratio
 3.88 3.88 4.15 5.22 8.63
Cash Ratio
 2.68 2.68 3.29 4.50 7.53
Solvency Ratio
 -0.58 -0.82 -0.56 -1.75 -1.72
Operating Cash Flow Ratio
 -1.04 -1.28 -0.94 -1.89 -2.28
Short-Term Operating Cash Flow Coverage
 0.00 -18.12 0.00 0.00 -3.93
Net Current Asset Value
€ 13.08M€ 13.08M€ 20.52M€ 26.70M€ 42.98M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.04 0.04 0.01
Debt-to-Equity Ratio
 0.06 0.06 0.06 0.04 0.02
Debt-to-Capital Ratio
 0.06 0.06 0.05 0.04 0.02
Long-Term Debt-to-Capital Ratio
 <0.01 0.05 0.00 0.00 0.00
Financial Leverage Ratio
 1.26 1.26 1.29 1.22 1.15
Debt Service Coverage Ratio
 0.00 -7.47 -35.31 -143.87 -3.15
Interest Coverage Ratio
 0.00 -12.63 -52.81 -159.93 -40.84
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.01
Interest Debt Per Share
 0.06 0.09 0.07 0.07 0.04
Net Debt to EBITDA
 2.09 1.40 4.49 1.91 3.72
Profitability Margins
Gross Profit Margin
94.98%81.99%97.74%95.54%96.81%
EBIT Margin
-101.83%-129.53%-60.52%-734.45%-403.96%
EBITDA Margin
-92.78%-119.54%-48.28%-717.78%-387.43%
Operating Profit Margin
-80.41%-129.53%-71.00%-766.32%-394.37%
Pretax Profit Margin
-77.35%-93.06%-63.15%-736.94%-403.29%
Net Profit Margin
-72.68%-87.89%-63.15%-736.94%-403.46%
Continuous Operations Profit Margin
-72.68%-87.87%-63.15%-736.94%-403.46%
Net Income Per EBT
93.96%94.44%100.00%100.00%100.04%
EBT Per EBIT
96.20%71.85%88.95%96.17%102.26%
Return on Assets (ROA)
-13.66%-18.99%-15.34%-32.26%-19.25%
Return on Equity (ROE)
-16.70%-23.92%-19.73%-39.37%-22.09%
Return on Capital Employed (ROCE)
-17.86%-33.08%-20.86%-39.08%-20.75%
Return on Invested Capital (ROIC)
-17.63%-30.83%-20.40%-37.35%-19.87%
Return on Tangible Assets
-15.18%-22.89%-16.91%-35.07%-20.44%
Earnings Yield
-3.93%-3.36%-3.34%-4.31%-3.77%
Efficiency Ratios
Receivables Turnover
 1.14 1.31 2.07 0.59 0.72
Payables Turnover
 0.07 0.30 0.07 0.03 0.04
Inventory Turnover
 6.06 24.96 0.00 0.00 0.00
Fixed Asset Turnover
 3.72 4.28 5.04 0.97 2.78
Asset Turnover
 0.19 0.22 0.24 0.04 0.05
Working Capital Turnover Ratio
 0.42 0.39 0.39 0.06 0.07
Cash Conversion Cycle
 -4.57K -906.75 -5.34K -11.92K -8.43K
Days of Sales Outstanding
 321.13 279.36 176.58 623.49 510.46
Days of Inventory Outstanding
 60.25 14.62 0.00 0.00 0.00
Days of Payables Outstanding
 4.95K 1.20K 5.51K 12.54K 8.94K
Operating Cycle
 381.39 293.98 176.58 623.49 510.46
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.19 -0.24 -0.23 -0.46 -0.48
Free Cash Flow Per Share
 -0.19 -0.24 -0.23 -0.47 -0.51
CapEx Per Share
 <0.01 <0.01 <0.01 0.01 0.03
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.02 1.06
Dividend Paid and CapEx Coverage Ratio
 -1.33K -1.65K -231.14 -42.98 -17.80
Capital Expenditure Coverage Ratio
 -1.33K -1.65K -231.14 -42.98 -17.80
Operating Cash Flow Coverage Ratio
 -3.30 -3.89 -3.69 -7.31 -14.86
Operating Cash Flow to Sales Ratio
 -0.85 -0.92 -0.67 -6.14 -4.46
Free Cash Flow Yield
-4.53%-3.50%-3.54%-3.67%-4.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -24.69 -29.74 -29.73 -23.21 -26.50
Price-to-Sales (P/S) Ratio
 17.86 26.14 18.91 171.06 106.92
Price-to-Book (P/B) Ratio
 4.17 7.11 5.91 9.14 5.85
Price-to-Free Cash Flow (P/FCF) Ratio
 -21.04 -28.54 -28.21 -27.24 -22.71
Price-to-Operating Cash Flow Ratio
 -20.76 -28.56 -28.34 -27.87 -23.99
Price-to-Earnings Growth (PEG) Ratio
 5.43 -6.54 0.50 -0.93 11.92
Enterprise Value Multiple
 -17.16 -20.46 -34.69 -21.92 -23.87
Enterprise Value
 105.44M 176.29M 168.15M 328.35M 272.94M
EV to EBITDA
 -18.13 -20.46 -34.69 -21.92 -23.87
EV to Sales
 16.82 24.46 16.75 157.33 92.49
EV to Free Cash Flow
 -19.81 -26.71 -24.98 -25.05 -19.65
EV to Operating Cash Flow
 -19.82 -26.73 -25.09 -25.64 -20.75
Tangible Book Value Per Share
 0.84 0.75 0.97 1.26 1.89
Shareholders’ Equity Per Share
 0.96 0.96 1.11 1.40 1.98
Tax and Other Ratios
Effective Tax Rate
 -0.06 0.06 0.01 0.04 >-0.01
Revenue Per Share
 0.23 0.26 0.35 0.07 0.11
Net Income Per Share
 -0.17 -0.23 -0.22 -0.55 -0.44
Tax Burden
 0.94 0.94 1.00 1.00 1.00
Interest Burden
 0.76 0.72 1.04 1.00 1.00
Research & Development to Revenue
 1.40 1.57 1.02 6.91 3.44
SG&A to Revenue
 0.60 0.68 0.56 2.66 1.19
Stock-Based Compensation to Revenue
 0.08 0.09 -0.05 0.26 0.19
Income Quality
 1.17 1.04 1.06 0.83 1.22
Currency in EUR